Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate and Severe Rheumatoid Arthritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03618784
What this trial is testing

Safety and Efficacy of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Kang Stem Biotech Co., Ltd. 33
Post-approval studies (Phase 4)Study completedNCT01961271
What this trial is testing

Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain

Who this might be right for
OsteoarthritisRheumatoid ArthritisLower Back Pain+2 more
Mundipharma Pte Ltd. 114
Testing effectiveness (Phase 2)WithdrawnNCT02795299
What this trial is testing

Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bird Rock Bio, Inc.
Large-scale testing (Phase 3)Ended earlyNCT01202773
What this trial is testing

A Study in Participants With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 456
Early research (Phase 1)Looking for participantsNCT07207954
What this trial is testing

Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Lifordi Immunotherapeutics, Inc. 176
Early research (Phase 1)Ended earlyNCT03161457
What this trial is testing

JHL1101 Versus MabThera® in Subjects With Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid ArthritisArthritis, Rheumatoid
JHL Biotech, Inc. 153
Large-scale testing (Phase 3)Study completedNCT01936181
What this trial is testing

A Study Comparing SB2 to Remicade® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy

Who this might be right for
Rheumatoid Arthritis
Samsung Bioepis Co., Ltd. 584
Testing effectiveness (Phase 2)Ended earlyNCT02393378
What this trial is testing

Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Takeda 7
Large-scale testing (Phase 3)UnknownNCT05725434
What this trial is testing

Evaluate Usability of Subcutaneous Auto-injector of CT-P47 in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Celltrion 30
Post-approval studies (Phase 4)Study completedNCT01500278
What this trial is testing

Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate

Who this might be right for
Rheumatoid Arthritis
UCB Pharma SA 915
Large-scale testing (Phase 3)Study completedNCT02114931
What this trial is testing

Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Amgen 467
Large-scale testing (Phase 3)Study completedNCT02937701
What this trial is testing

Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Infliximab

Who this might be right for
Arthritis, Rheumatoid
Amgen 558
Testing effectiveness (Phase 2)WithdrawnNCT05217472
What this trial is testing

An Efficacy and Safety Study of Injectable Ravagalimab to Assess Change in EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) in Adult Participants With Moderately to Severely Active Primary Sjogren's Syndrome (pSS)

Who this might be right for
Sjogren's Syndrome (SS)
AbbVie
Testing effectiveness (Phase 2)Ended earlyNCT06859294
What this trial is testing

LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 35
Large-scale testing (Phase 3)Study completedNCT02293902
What this trial is testing

A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI)

Who this might be right for
Rheumatoid Arthritis
Sanofi 243
Large-scale testing (Phase 3)Study completedNCT00951275
What this trial is testing

Tocilizumab + DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 105
Large-scale testing (Phase 3)Study completedNCT02480153
What this trial is testing

PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).

Who this might be right for
Rheumatoid Arthritis
Pfizer 597
Large-scale testing (Phase 3)Study completedNCT01734993
What this trial is testing

A Long-Term Extension Study of WA22762 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA).

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 11
Early research (Phase 1)Active Not RecruitingNCT06175338
What this trial is testing

Study, Evaluating Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety Profiles of Rituximab Compared to MabThera® in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Mabscale, LLC 208
Large-scale testing (Phase 3)Study completedNCT05814627
What this trial is testing

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AbbVie 487
Next Page